Use of the Haemophilus influenzae type b vaccine among preschool attendees.
Use of the Hib vaccine during the first 15 months after licensure was studied in a university-based preschool program. Questionnaires were sent to the parents of the 176 children, ages 29-82 months, enrolled; 115 questionnaires (65.3%) were returned. Fifty seven children (49.6%) had received the Hib vaccine; the mean age at immunization was 40.6 months (range, 22-70 months). Of the 17 children who were under age 24 months at the time of vaccine licensure (April 1985), 14 (82%) were ultimately immunized. One child (age 22 months) received the vaccine before age 24 months. At 15 months after licensure, 80 percent of the 2-year-old children were immunized; 78 percent of 3 year olds; 55 percent of 4 year olds; 15 percent of 5 year olds; and 17 percent of 6 year olds. Thus, although the vaccine was underused as defined by the current recommendations for this group of children, the majority of children at greatest risk for disease--those under age 4 years--were immunized.
Gilsdorf
J R
JR
C. S. Mott Children's Hospital, Ann Arbor, Michigan.
D000367:Age Factors; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D006193:Haemophilus influenzae / Q000276:immunology*; D006801:Humans; D007223:Infant; D012307:Risk Factors; D011795:Surveys and Questionnaires; D014611:Vaccination / Q000706:statistics & numerical data
D001428:Bacterial Vaccines